Director, Centre of Technology Development, Duke-NUS Medical School Singapore
• Speaker, Commercialisation and Translation Symposium, 18 Sep 2021
Dr David Wang is the Director of Centre of Technology Development at Duke-NUS Medical School Singapore. Dr Wang has years of experience in intellectual property management, technology acceleration and commercialisation, and new ventures.
From 2017 to 2020, Dr Wang was a Senior Acceleration Manager at Cincinnati Children’s Innovation Ventures, an international leader in pediatric medicine, research and education. He led the assessment, identification, and acceleration management of Cincinnati Children’s most promising biomedical programmes. Thus, resulting in translational value creation and closure of massive transactions in licensing, product co-development, and venture investment.
Dr Wang received the Educational Institution and Federal Laboratory Partnership Award 2020, for his outstanding work in technology transfer and management of collaboration between Cincinnati Children’s and NIH. Prior to joining Cincinnati Children’s, Dr Wang founded a life science company and secured $6 million in venture funding for the company. As the company’s founder, he managed the whole cycle of product development and translated pioneering concepts into FDA-approved proprietary products.
Previously, Dr Wang has worked for a number of years as a senior innovation manager at Cleveland Clinic and at the University of Rochester, and as a drug discovery scientist at Pfizer. He received his Bachelor and Master of Medicine degrees from Hunan Medical University in China, and received his MBA from the University of Michigan.